{"id":19470,"date":"2022-02-03T08:15:25","date_gmt":"2022-02-03T13:15:25","guid":{"rendered":"https:\/\/medicarereport.org\/?p=19470"},"modified":"2022-02-03T08:15:26","modified_gmt":"2022-02-03T13:15:26","slug":"researchers-label-early-car-t-therapy-patient-cured-after-living-a-decade-without-cancer","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=19470","title":{"rendered":"Researchers label early CAR-T therapy patient \u2018cured\u2019 after living a decade without cancer"},"content":{"rendered":"\n<p>(By Angus Chen for ST<em>A<\/em>T)<\/p>\n\n\n\n<p>In 2010, Doug Olson became the second person in the world to receive CAR-T cell therapy, an experimental tactic to engineer his own immune cells to fight cancer. His doctors had tempered expectations for how well it would fight off Olson\u2019s chronic lymphocytic leukemia, an incurable blood cancer \u2014 it was a last stab in the dark, one with no guarantees.  Continue reading <a href=\"https:\/\/www.statnews.com\/2022\/02\/02\/cart-cancer-therapy-leukemia-treatment\/\" data-type=\"URL\" data-id=\"https:\/\/www.statnews.com\/2022\/02\/02\/cart-cancer-therapy-leukemia-treatment\/\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"21\" class=\"wp-image-4372\" style=\"width: 200px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/p>\n\n\n\n<pre class=\"wp-block-preformatted\"><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Angus Chen for STAT) In 2010, Doug Olson became the second person in the world to receive CAR-T cell<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-19470","post","type-post","status-publish","format-standard","hentry","category-medical-technology"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19470"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19470\/revisions"}],"predecessor-version":[{"id":19471,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19470\/revisions\/19471"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}